IP Library Granted Patent US 9,775,933
Granted Patent B2
US 9,775,933 · App. 13/773,937 · Granted Oct 3, 2017

Biocompatible surfaces and devices incorporating such surfaces

Inventors: Keith A. Knisley (Flagstaff, AZ); Vishnu T. Marla (Newark, DE); Rachel Radspinner (Flagstaff, AZ); Paul A. Silvagni (Flagstaff, AZ); Jason J. Strid (Elkton, MD); Michael J. Vonesh (Flagstaff, AZ)
Assignee: W. L. Gore & Associates, Inc.
A61L31/06A61F2/0077A61F2/82A61L31/048A61L31/10A61L31/146A61L31/16A61L33/007A61L33/064A61F2002/009A61L2300/416A61L2300/42A61L2400/12A61L2400/18
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,775,933
App. No.
13/773,937
Granted
Oct 3, 2017
Kind
B2
Abstract

The invention is an improved biocompatible surface for a variety of medical purposes. The biocompatible surface employs a unique tight microstructure that demonstrates enhanced cellular response in the body, particularly when placed in contact with blood. As a blood contact surface, the present invention can be beneficially employed in a wide variety of implantable devices and in many other devices and equipment that come in contact with blood.

Claims (19)

1. A blood contact surface comprising

a polytetrafluoroethylene microstructure of nodes and fibrils in both an x direction and in a substantially perpendicular y direction;

wherein the nodes and fibrils have a mean distance between adjacent nodes of 5 micron or less; and

wherein the mean width of the 32 largest nodes in a representative 10,000× SEM micrograph is less than about 1.5 micron.

2. The blood contact surface of claim 1 wherein the nodes and fibrils have a ratio of mean distances between adjacent nodes in the x and y directions of about 2:1 to 1.1.

3. The blood contact surface of claim 2 wherein the ratio of mean distances between adjacent nodes in the x and y directions is about 1:1.

4. The blood contact surface of claim 1 wherein the expanded polytetrafluoroethylene comprises a multi-axially expanded polytetrafluoroethylene.

5. The blood contact surface of claim 4 wherein the expanded polytetrafluoroethylene comprises a bi-axially expanded polytetrafluoroethylene.

6. The blood contact surface of claim 1 wherein the expanded polytetrafluoroethylene comprises fibrils extended outwardly from the nodes in substantially perpendicular directions.

7. The blood contact surface of claim 1 wherein the mean width of the nodes comprises less than about 1.25 micron.

8. The blood contact surface of claim 1 wherein the mean width of the nodes is less than about 1 micron.

9. The blood contact surface of claim 1 wherein the ratio of mean distances between adjacent nodes in the x and y directions is less than 1.5 to 1.

10. The blood contact surface of claim 1 wherein the microstructure substantially prevents cellular in-growth.

11. The blood contact surface of claim 1 wherein the blood contact surface is incorporated in an implantable medical device.

12. The blood contact surface of claim 1 wherein the blood contact surface is incorporated in a non-implantable medical device.

13. The blood contact surface of claim 1 wherein the mean distance between adjacent nodes is less than about 4 micron.

14. The blood contact surface of claim 13 wherein the mean distance between adjacent nodes is less than about 3 micron.

15. The blood contact surface of claim 11 wherein the implantable medical device includes a stent.

16. The blood contact surface of claim 1 wherein endothelial cells attach intimately to the node and fibril microstructure.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 18, 2013
From: KNISLEY, KEITH A.; MARLA, VISHNU T.; RADSPINNER, RACHEL; SILVAGNI, PAUL A.; STRID, JASON J.; VONESH, MICHAEL J.
To: W. L. GORE & ASSOCIATES, INC.
Reel/Frame 031032/0424 →
Continuity (2)
Provisional Application 61606020 · Mar 2, 2012
Related Publication 20130231733A1 · Sep 5, 2013